CBDG / THC Farmaceuticals, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

THC Farmaceuticals, Inc.
US ˙ OTCPK

Mga Batayang Estadistika
CIK 1508594
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to THC Farmaceuticals, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
April 24, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to the Securities Exchange Act of 1933 Date of Report (Date of earliest event reported) April 24, 2024 THC FARMACEUTICALS, INC. formerly, City Media, Inc. (Exact name of registrant as specified in its charter) COLORADO (State or other jurisdiction of incorporation) 000-54754 (Commission File No

April 2, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to the Securities Exchange Act of 1933 Date of Report ( Date of earliest event reported ) March 27, 2024 (March 26, 2024) THC FARMACEUTICALS, INC. formerly, City Media, Inc. (Exact name of registrant as specified in its charter) COLORADO (State or other jurisdiction of incorporation) 000-54754

November 28, 2017 15-12G

CBDG / THC Farmaceuticals, Inc CBDS FORM 15

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-54754 THC Farmaceuticals, Inc. (Exact name of registrant as specified i

September 3, 2015 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report ( Date of earliest event reported) September 1, 2015 ( August 27, 2015) THC FARMACEUTICALS, INC. formerly, City Media, Inc. (Exact name of registrant as specified in its charter) UTAH (State or other jurisdiction of in

August 19, 2015 10-Q

THC Farmaceuticals 10-Q (Quarterly Report)

THC Farmaceuticals, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-54754 THC Farmaceuticals, Inc. (Exact Na

August 19, 2015 10-Q/A

THC Farmaceuticals 10-Q/A (Quarterly Report)

THC Farmaceuticals, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) x QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-54754 THC Farmaceut

August 14, 2015 NT 10-Q

THC Farmaceuticals NT 10-Q

THC Farmaceuticals, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-54754 NOTIFICATION OF LATE FILING CUSIP NUMBER 177887 106 (Check One): ? Form 10-K ?Form 20-F ?Form 11-K x Form 10-Q ?Form 10-D ?Form N-SAR ?Form N-CSR For Period Ended: June 30, 2015 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report o

June 29, 2015 8-K

THC Farmaceuticals THC FARMACEUTICALS, INC. FORM 8-K (6/25/2015) (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report ( Date of earliest event reported) June 25, 2015 ( June 15, 2015) THC FARMACEUTICALS, INC. formerly, City Media, Inc. (Exact name of registrant as specified in its charter) UTAH (State or other jurisdiction of incorpor

June 12, 2015 EX-10.1

ASSET PURCHASE AGREEMENT

Exhibit 10.1 ASSET PURCHASE AGREEMENT This Asset Purchase Agreement (this "Agreement"), dated June 9th, 2015, is made between THC Farmaceuticals, Inc., a Utah corporation located at 7170 E. McDonald Drive, Suite 3, Scottsdale, Arizona 85253 (the "Seller") and Rocky Mountain Ayre, Inc., a Delaware Corporation located at 3500 South Dupont Highway, Dover, Delaware 19901 (the "Buyer" or "RMTN"). RECIT

June 12, 2015 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report ( Date of earliest event reported) June 11, 2015 ( June 9, 2015) THC FARMACEUTICALS, INC. formerly, City Media, Inc. (Exact name of registrant as specified in its charter) UTAH (State or other jurisdiction of incorpora

May 20, 2015 8-K

THC Farmaceuticals THC FARMACEUTICALS, INC. FORM 8-K (03/15/2015) (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report ( Date of earliest event reported) May 19, 2015 ( May 15, 2015) THC FARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) UTAH (State or other jurisdiction of incorporation) 000-54754 (Commission

April 13, 2015 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report ( Date of earliest event reported) April 10, 2015 ( April 3, 2015) THC FARMACEUTICALS, INC. formerly, City Media, Inc. (Exact name of registrant as specified in its charter) UTAH (State or other jurisdiction of incorpo

March 20, 2015 EX-3.1

EX-3.1

Exhibit 3.1

March 20, 2015 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report ( Date of earliest event reported) March 19, 2015 (February 15, 2015 ) THC FARMACEUTICALS, INC. formerly, City Media, Inc. (Exact name of registrant as specified in its charter) UTAH (State or other jurisdiction of inc

March 20, 2015 EX-10.1

ASSIGNMENT OF APPLICATION

A tto r ne y D o c k et N o . THC-002 Exhibit 10.1 ASSIGNMENT OF APPLICATION WHEREAS, Sadia "Ross" Barrameda, hereinafter referred to as the ASSIGNOR, has invented certain Improvements relating to METHODS OF PRODUCING ANTIBODY-RICH CANNABIS AND HONEYSUCKLE PLANTS, said improvements being described and/or claimed in the following patent application(s): U.S. Patent Application No. 14/564,672, filed

January 6, 2015 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 5, 2015 (January 5, 2015) CITY MEDIA, INC. (Exact name of registrant as specified in its charter) UTAH (State or other jurisdiction of incorporation) 000-54754 (Commission File

January 6, 2015 EX-10.1

SECURITIES PURCHASE AGREEMENT

EX-10.1 2 exh10-1.htm SECURITIES PURCHASE AGREEMENT WITH LAS VEGAS CANNABIS INFO CENTER Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (the "Agreement"), is entered into as of December 5 , 2014 by and between Las Vegas Cannabis Info Center, a Nevada corporation, located at 6171 S. Las Vegas Blvd., Suite 210, Las Vegas, Nevada 89119 (referred to herein as the "Company

January 6, 2015 EX-10.2

ASSET PURCHASE AGREEMENT

Exhibit 10.2 ASSET PURCHASE AGREEMENT This Asset Purchase Agreement (this "Agreement"), dated January 5, 2014, is made between David Tobias (the "Seller") and City Media, Inc., a Utah corporation (the "Buyer"). RECITALS WHEREAS, the Buyer desires to acquire certain assets of Seller in consideration of issuing 3,000,000 restricted shares of Buyer's common stock to Seller. WHEREAS, capitalized terms

January 6, 2015 8-K/A

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A-1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 5, 2015 (January 5, 2015) CITY MEDIA, INC. (Exact name of registrant as specified in its charter) UTAH (State or other jurisdiction of incorporation) 000-54754 (Commission

December 24, 2014 SC 14F1

CBDG / THC Farmaceuticals, Inc SC 14F1 - - CITY MEDIA, INC. FORM 14(F-1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INFORMATION FILED PURSUANT TO SECTION 14(f) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report December 18, 2014 CITY MEDIA, INC. (Exact name of registrant as specified in its chart er) UTAH (State or other jurisdiction of incorporation) 000-54754 26-1805170 (Commission File No.) (IRS Employer ID) 5635 N. Scottsdale Road Sc

December 23, 2014 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 23, 2014 (December 1, 2014) CITY MEDIA, INC. (Exact name of registrant as specified in its charter) UTAH (State or other jurisdiction of incorporation) 000-54754 (Commission F

November 25, 2014 EX-99.3

JOINT FILING AGREEMENT

EXHIBIT 99.3 JOINT FILING AGREEMENT This Agreement will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on the date hereof with respect to the beneficial ownership by the undersigned of the shares of common stock, $0.01 par value per share, of City Media, Inc. is being filed, and all amendments thereto will be filed, on beh

November 25, 2014 EX-99.2

EX-99.2

EXHIBIT 99.2

November 25, 2014 SC 13D

CBDG / THC Farmaceuticals, Inc / Weed Growth Fund, Inc. - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) City Media, Inc. (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securities) 177887 106 (CUSIP Number) WEED GROWTH FUND, INC. 130 N. Scottsdale Road, S

November 25, 2014 EX-99.1

EX-99.1

EXHIBIT 99.1

November 21, 2014 SC 13D/A

CBDG / THC Farmaceuticals, Inc / Aguirre Jennifer A - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D/A Amendment No. 1 (Under the Securities Exchange Act of 1934) City Media, Inc. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 177887 106 (CUSIP Number) Victor D. Schwarz, Esq. 999 Murray Holladay Road, Suite 101 Salt Lake City, UT 84117 (801)-270-0930 (Name, Address and Telephone Number of Pe

November 21, 2014 SC 13D/A

CBDG / THC Farmaceuticals, Inc / Jones Calvin K - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D/A Amendment No. 1 (Under the Securities Exchange Act of 1934) City Media, Inc. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 177887 106 (CUSIP Number) Victor D. Schwarz, Esq. 999 Murray Holladay Road, Suite 101 Salt Lake City, UT 84117 (801)-270-0930 (Name, Address and Telephone Number of Pe

November 21, 2014 SC 13D/A

CBDG / THC Farmaceuticals, Inc / Jenson Travis T - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D/A (Under the Securities Exchange Act of 1934) City Media, Inc. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 177887 106 (CUSIP Number) Travis T. Jenson 1411 E. Crescent Drive North Park City, UTAH 84098 (801)-641-5453 (Name, Address and Telephone Number of Person Authorized to Receive Notice

November 21, 2014 SC 13D/A

CBDG / THC Farmaceuticals, Inc / Trimble Kelly - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D/A Amendment No. 1 (Under the Securities Exchange Act of 1934) City Media, Inc. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 177887 106 (CUSIP Number) Victor D. Schwarz, Esq. 999 Murray Holladay Road, Suite 101 Salt Lake City, UT 84117 (801)-270-0930 (Name, Address and Telephone Number of Pe

November 21, 2014 SC 13D/A

CBDG / THC Farmaceuticals, Inc / HOWELLS THOMAS J - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D/A Amendment No. 1 (Under the Securities Exchange Act of 1934) City Media, Inc. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 177887 106 (CUSIP Number) Thomas Howells 4685 S. Highland Drive, Suite 202 Salt Lake City, UT 84117 (801)-278-9424 (Name, Address and Telephone Number of Person Author

November 20, 2014 EX-10.2

LOCK-UP/LEAK-OUT AGREEMENT

EX-10.2 2 exh10-2.htm LOCK UP AGREEMENT Exhibit 10.2 LOCK-UP/LEAK-OUT AGREEMENT THIS LOCK-UP/LEAK-OUT AGREEMENT (the "Agreement") is between City Media, Inc., a Utah corporation (the "Company"), and the undersigned person or entity listed on the Counterpart Signature Page hereof, sometimes referred to herein as the "Shareholder." For all purposes of this Agreement, "Shareholder" includes any "affi

November 20, 2014 8-K

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 20, 2014 (November 18, 2014) CITY MEDIA, INC. (Exact name of registrant as specified in its charter) UTAH (State or other jurisdiction of incorporation) 000-54754 (Commission

November 14, 2014 EX-16

[Mantyla McReynolds logo]

[Mantyla McReynolds logo] November 14, 2014 Securities and Exchange Commission 100 F Street N.

November 14, 2014 8-K/A

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 7, 2014 (Date of Report: Date of earliest event reported) City Media, Inc. (Exact name of registrant as specified in its charter) Utah 333-171488 26-1805170 (State or other jurisdiction of incorporation) (Commission File N

November 12, 2014 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 7, 2014 (Date of Report: Date of earliest event reported) City Media, Inc. (Exact name of registrant as specified in its charter) Utah 333-171488 26-1805170 (State or other jurisdiction of incorporation) (Commission File Num

November 12, 2014 EX-16

[Mantyla McReynolds logo]

[Mantyla McReynolds logo] November 10, 2014 Securities and Exchange Commission 100 F Street N.

February 14, 2014 EX-10.1

CITY MEDIA, INC. CONVERTIBLE PROMISSORY NOTE

EX-10.1 2 citymedia10qdec13ex10.htm CITY MEDIA, INC. - EXHIBIT 10.1 - FORM OF CONVERTIBLE PROMISSORY NOTE Exhibit 10.1 Form of Convertible Promissory Note issued to those individuals listed on Exhibit B hereto. CITY MEDIA, INC. CONVERTIBLE PROMISSORY NOTE THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY S

February 14, 2014 10-Q

THC Farmaceuticals CITY MEDIA, INC. - 10Q 12-31-13 (Quarterly Report)

10-Q 1 citymedia10qdec13.htm CITY MEDIA, INC. - 10Q 12-31-13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition peri

August 23, 2012 8-K

Other Events - CITY MEDIA, INC. - 8K - AUGUST 23, 2012

United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15[d] of the Securities Exchange Act of 1934 August 23, 2012 Date of Report [Date of Earliest Event Reported] CITY MEDIA, INC. (Exact name of Registrant as specified in its Charter) Utah 333-171488 26-1805170 (State or Other Jurisdiction of (Commission File Number) (I.R.S. Empl

July 23, 2012 SC 13D

CBDG / THC Farmaceuticals, Inc / Aguirre Jennifer A - SCHEDULE 13D FOR JENNIFER AQUIRRE Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D (Under the Securities Exchange Act of 1934) City Media, Inc. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 177887 106 (CUSIP Number) Victor D. Schwarz, Esq. 999 Murray Holladay Road, Suite 101 Salt Lake City, UT 84117 (801)-270-0930 (Name, Address and Telephone Number of Person Authorized to Receive Notic

July 23, 2012 SC 13D

CBDG / THC Farmaceuticals, Inc / Jones Calvin K - SCHEDULE 13D FOR CALVIN K. JONES Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D (Under the Securities Exchange Act of 1934) City Media, Inc. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 177887 106 (CUSIP Number) Victor D. Schwarz, Esq. 999 Murray Holladay Road, Suite 101 Salt Lake City, UT 84117 (801)-270-0930 (Name, Address and Telephone Number of Person Authorized to Receive Notic

July 20, 2012 SC 13D

CBDG / THC Farmaceuticals, Inc / Trimble Kelly - SCHEDULE D FOR KELLY TRIMBLE Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D (Under the Securities Exchange Act of 1934) City Media, Inc. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 177887 106 (CUSIP Number) Victor D. Schwarz, Esq. 999 Murray Holladay Road, Suite 101 Salt Lake City, UT 84117 (801)-270-0930 (Name, Address and Telephone Number of Person Authorized to Receive Notic

July 18, 2012 SC 13D

CBDG / THC Farmaceuticals, Inc / HOWELLS THOMAS J - SCHEDULE D FOR THOMAS J. HOWELLS Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D (Under the Securities Exchange Act of 1934) City Media, Inc. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 177887 106 (CUSIP Number) Thomas Howells 4685 S. Highland Drive, Suite 202 Salt Lake City, UT 84117 (801)-278-9424 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Comm

July 18, 2012 SC 13D

CBDG / THC Farmaceuticals, Inc / Jenson Travis T - SCHEDULE D FOR TRAVIS T. JENSON Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D (Under the Securities Exchange Act of 1934) City Media, Inc. (Name of Issuer) Common Voting Stock (Title of Class of Securities) 177887 106 (CUSIP Number) Thomas Howells 4685 S. Highland Drive, Suite 202 Salt Lake City, UT 84117 (801)-278-9424 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Comm

June 29, 2012 8-A12G

- CITY MEDIA, INC. - FORM 8-A 12G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-171488 CITY MEDIA, INC. (Exact Name of Registrant as specified in its charter) Utah 26-1805170 (State or other jurisdiction of incorporation) (I.R.S. Employer I.D. No.)

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista